Pharmaceutical Headlines for 20 may 2011 ( Friday ) !

Pharmaceutical Headlines for 20 may 2011 ( Friday ) !

• AstraZeneca PLC (AZN) Chops Jobs in Massachusetts More...

• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Destroyed Shareholder Value More Than Any Drugmaker More...


• AstraZeneca PLC (AZN) Rumored to be Eyeing Up US Target, Analysts Believe Cubist Pharmaceuticals, Inc. (CBST) to be a Possibility More...


• Ridgemont Equity Takes Majority Stake In Gallus Biopharmaceuticals LLC More...

• Pfizer Inc. (PFE) Pays $7.5 Million Regulatory Milestone to Auxilium Pharmaceuticals (AUXL) More...


• Baylor College of Medicine and Golden Helix Collaborate to Put Better Rare Variant Analysis into the Hands of Researchers More...


• Logos Technologies Joins Medidata Solutions, Inc. Technology Partner Program More...


• ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for Ulipristal Acetate to Treat Uterine Fibroids in Japan More...


• Titertek Instruments, Inc. and Berthold Technologies Have Joined Forces More...

• EMD Serono, Inc. (Rockland) President and CEO Fereydoun Firouz Resigns More...


• Geron Corporation (GERN) Promotes, Adds to Executive Team More...


• Board Evolution at BioAlliance to Support Its Growth Strategy More...


• MorphoSys AG Announces Re-election of Two Supervisory Board Members More...


• Shareholders OctoPlus Appoint Jan Egberts to Executive Board More...


• China Ruitai International Holdings Co., Ltd. Reports First Quarter 2011 Results More...


• Cyclodextrin Technologies Development, Inc. (CTDI) Reports Record 1st Quarter 2011 Sales More...


• Neuland Labs Reports Financial Results for Fiscal Year 2011 More...


• Tibet Pharmaceuticals Announces Availability of First Quarter 2011 Earnings Call Transcript More...

• FDA Approves Tibotec's HIV Drug Edurant More...

• Pfizer Inc. (PFE): ELIQUIS(R) (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement More...

• American Regent, Inc. Initiates Nationwide Voluntary Recall of Sterile Water for Injection, USP, 50 mL Single Dose Vial Due to Particulate Matter More...

• CHMP Issues Positive Opinion for Merck & Co., Inc. (MRK)'s VICTRELISTM (boceprevir), Oral Hepatitis C Virus (HCV) Protease Inhibitor More...

• Amgen (AMGN) Receives CHMP Positive Opinion for XGEVA(TM) (Denosumab) in the European Union More...

• Biogen Idec, Inc. (Massachusetts) (BIIB): European Medicines Agency's Committee for Medicinal Products for Human Use Issues Positive Opinion on Marketing Authorization Application for FAMPYRA More...


• Acorda Therapeutics (ACOR) Statement on CHMP Positive Opinion on Marketing Authorization Application for FAMPYRA(R) in Europe More...

• INSYS Therapeutics Announces NDA PDUFA Date for Fentanyl SL SprayMore...

• FDA Panel Calls for New Trial on Abbott Laboratories (ABT)'s Trilipix More...

• Progenics Pharmaceuticals, Inc. (PGNX) Announces Results of Methylnaltrexone Phase 3 Safety Study in Chronic, Non-Malignant Pain PatientsMore...

• Onyx Pharmaceuticals, Inc. (ONXX) Announces Updated Pivotal Carfilzomib Phase 2B Data More...

• Medivir AB (MVIRb.F) Announces Positive 48-week Interim Data from TMC435 Hepatitis C Phase 2b ASPIRE Study in Treatment-Experienced Genotype-1 Patients More...

• Viagra Could Reduce Multiple Sclerosis Symptoms, Autonoma de Barcelona Study More...

• Supplements 'Reduce Risk of Pre-Eclampsia' - Universidad Nacional Study More...

• New Drug Targets for Squamous Cell Carcinoma, Fred Hutchinson Cancer Research Center Study More...

• U.S. Navy Doctor's Drug Study Under Scrutiny More...

• Study Finds 10% of Cancer Patients Abandon Oral Anti-Cancer Medications,Avalere Health Study Finds More...


( Source: Biospace )
Tags: ,

About author

Make it happen !!

0 comments

Leave a Reply

Related Posts Plugin for WordPress, Blogger...